Ibis Prepares Next-Gen Microorganism Detector For Diagnostic Space

Five years ago the U.S. Department of Defense commissioned California-based Isis Pharmaceuticals to develop a new technology to more easily detect bioterrorism agents. Now, $55.6 million in government grants later, the company is readying the Ibis T5000 Biosensor System to make its way into the in vitro diagnostics space